On the other hand, OSM administration attenuated oxidative stress‐induced cardiac ischemia/reperfusion injury by inhibiting cardiomyocyte apoptosis through upregulating Bcl‐2 expression [44]. Here, BCL2 is linked to myocardial ischemia.